group-women-sports-teams

Newsroom

Take a look inside our world

Press Releases

AJOVY® (fremanezumab-vfrm) Significantly Reduced Monthly Migraine and Headache Days in Children and Adolescents with Episodic Migraine Compared to Placebo in the SPACE Trial; Results Published in New England Journal of Medicine

Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference: Pivot to Growth Strategy Delivering Growth and Transforming through Innovation

Teva and Royalty Pharma Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo

Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference

S&P Global Ratings Upgrades Teva to ‘BB+’ Amid Strong Execution of Pivot to Growth Strategy; Moody's Ratings Agency Revises Outlook to Positive

Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea®

Teva Releases Q4 2025 Aide Memoire

Teva to Host Conference Call to Discuss Fourth Quarter 2025 Financial Results at 8 a.m. ET on January 28, 2026

Teva Pharmaceuticals Submits New Drug Application to FDA for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults

Teva receives European Commission approvals for PONLIMSI® (denosumab) Biosimilar to Prolia® and DEGEVMA® (denosumab) Biosimilar to Xgeva®
View all press releases

Our Stories

Evan Lippman, Teva’s Executive Vice President of Business Development Global Innovation Research & Development

“I Think People are Starting to Get That There’s a Lot of Upside at Teva”

 Global Innovation Research & Development Patient Focus

Teva Rise: Accelerating Pharma Innovation Globally

 Person working in a factory. Sustainability Impact

Using Antibiotics Wisely. Making Them Responsibly.

 Global Innovation Global Operations

Building the Factory of the Future with Augmented Reality

 Innovation Growth

Q3 business highlights at a glance

 An illustration of a person with an open brain, where two small figures use ladders and tools to explore the inside. Patients caregivers Schizophrenia TD Mental Health Global Life Effects Patient Focus Caregivers Disease Awareness

Living with Schizophrenia and Tardive Dyskinesia: An Expert Perspective

 Patients caregivers Global Life Effects Humanizing Health Patient Focus Disease Awareness Caregivers

Taking time to listen: meeting a tardive dyskinesia patient

 Patients caregivers Global Life Effects Humanizing Health Patient Focus Caregivers Disease Awareness

Taking time to listen: meeting a schizophrenia patient

 Caregivers Disease Awareness Global Humanizing Health Life Effects Patient Focus Patients caregivers

Taking time to listen: meeting a schizophrenia carer

 Our People Innovation Health & Technology

3 Trends I’m Watching in Antibody Generation

 View all stories

Contacts for Media Inquiries

Grace Ann Arnold

North America

+1-973-2653670
GraceAnn.Arnold@tevapharm.com

Eden Klein

Israel & Corporate

+972-3-9062645
Eden.Klein@teva.co.il

Fiona Cohen

Europe

fiona.cohen@tevaeu.com

Teva Media Assets

These proprietary media assets are available for download and are intended for non-commercial media use and research only.

Download Logo Download Teva B-Roll

Connect with us on social media

Follow us on Facebook

Go to facebook.com

Follow us on Linkedin

Go to linkedin.com

Follow us on Twitter

Go to twitter.com